Newsmax reiterates $212M-$216M 2026 revenue outlook as affiliate and licensing expand
Post ContentRead More
Laird Superfood projects $138M-$148M 2026 net sales following Navitas and Terrasoul acquisitions
Post ContentRead More
Soybean futures slide with no export news from U.S.-China summit
Post ContentRead More
XBP outlines 20% workforce reduction and $55M-$60M annual efficiencies while exploring strategic alternatives
Post ContentRead More
Barfresh outlines fiscal 2026 guidance of $28M-$32M revenue and $3.2M-$3.8M adjusted EBITDA as Defiance facility targets commissioning before end of 2026
Post ContentRead More
Justices Allow Abortion Pill Access by Mail to Continue
Also, this is a big week for the art market. Here’s the latest at the end of Thursday.Read More
Renaissance Technologies adds Apple, exits Amazon, boosts Nvidia stake in Q1 among other trades
Post ContentRead More
Zeta joins Snowflake-led OSI; can one data standard fix AI chaos & YTD losses?
Post ContentRead More
Valion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling work
Post ContentRead More
Innovate outlines filings for more than 60 new spectrum licenses while DBM holds $1.8B adjusted backlog
Post ContentRead More